Fermata Advisors LLC Decreases Position in Procter & Gamble Company (The) $PG

Fermata Advisors LLC lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 29.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,361 shares of the company’s stock after selling 1,845 shares during the period. Fermata Advisors LLC’s holdings in Procter & Gamble were worth $695,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Benjamin Edwards Inc. raised its stake in Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock worth $62,098,000 after acquiring an additional 199,258 shares during the last quarter. Capital Investment Advisory Services LLC raised its stake in shares of Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock valued at $6,426,000 after buying an additional 4,562 shares during the last quarter. World Investment Advisors raised its stake in shares of Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock valued at $8,677,000 after buying an additional 2,886 shares during the last quarter. Concurrent Investment Advisors LLC raised its stake in shares of Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock valued at $20,451,000 after buying an additional 25,059 shares during the last quarter. Finally, Kelly Financial Services LLC raised its stake in shares of Procter & Gamble by 8.7% during the 1st quarter. Kelly Financial Services LLC now owns 1,727 shares of the company’s stock valued at $294,000 after buying an additional 138 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.8%

PG stock opened at $158.08 on Wednesday. The firm has a market cap of $369.98 billion, a PE ratio of 24.28, a PEG ratio of 4.14 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm’s 50 day moving average price is $156.14 and its 200-day moving average price is $161.62. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble’s payout ratio is presently 64.98%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on PG shares. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an “equal weight” rating in a research note on Thursday, July 31st. Evercore ISI reiterated an “in-line” rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. BNP Paribas reiterated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Finally, UBS Group set a $180.00 target price on Procter & Gamble and gave the company a “buy” rating in a research report on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $175.12.

Insider Buying and Selling

In other news, CEO Jennifer L. Davis sold 8,596 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the sale, the chief executive officer owned 64,991 shares of the company’s stock, valued at approximately $10,221,134.57. This represents a 11.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the company’s stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 over the last quarter. 0.20% of the stock is owned by corporate insiders.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.